Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 51% · prior close shown (market closed)
PFIZER INC shows stable business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +3% YoY in Q2 FY2026.
Watch: Absence of revenue data limits investor ability to assess top-line trajectory for the Global Biopharmaceuticals Business.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
Reported figures for PFIZER INC — research only, not investment advice.
Theme: Global Biopharmaceuticals Business
Updated
What happened recently for PFIZER INC (PFE) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$26.79
Market cap
$152.69B
Profitable
Yes
Revenue $62.58B
Net income
$7.77B
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for PFIZER INC — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow PFIZER INC through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.